TW202237756A - 改良美容效果的隱形眼鏡 - Google Patents

改良美容效果的隱形眼鏡 Download PDF

Info

Publication number: TW202237756A
Authority: TW; Taiwan
Prior art keywords: design; contact lens; pattern; eye; limbal
Prior art date: 2021-03-29

Application number

TW111111587A

Other languages

English (en)

Chinese (zh)

Inventor

艾許莉索維爾

艾德蒙喬利

阿納斯塔西婭柏爾根

Original Assignee

美商壯生和壯生視覺關懷公司

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2021-03-29

Filing date

2022-03-28

Publication date

2022-10-01

2022-03-09 Priority claimed from US17/654,122 external-priority patent/US20220306886A1/en

2022-03-28 Application filed by 美商壯生和壯生視覺關懷公司 filed Critical 美商壯生和壯生視覺關懷公司

2022-10-01 Publication of TW202237756A publication Critical patent/TW202237756A/zh

Links

230000000694 effects Effects 0.000 claims abstract description 312
239000000049 pigment Substances 0.000 claims abstract description 163
239000002537 cosmetic Substances 0.000 claims abstract description 121
239000000976 ink Substances 0.000 claims abstract description 86
210000003786 sclera Anatomy 0.000 claims abstract description 51
229910044991 metal oxide Inorganic materials 0.000 claims abstract description 44
150000004706 metal oxides Chemical class 0.000 claims abstract description 44
VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 24
PNEYBMLMFCGWSK-UHFFFAOYSA-N Alumina Chemical class [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 claims abstract description 13
ULGYAEQHFNJYML-UHFFFAOYSA-N [AlH3].[Ca] Chemical compound [AlH3].[Ca] ULGYAEQHFNJYML-UHFFFAOYSA-N 0.000 claims abstract description 13
229910052751 metal Inorganic materials 0.000 claims abstract description 12
239000002184 metal Substances 0.000 claims abstract description 12
239000000377 silicon dioxide Substances 0.000 claims abstract description 12
235000012239 silicon dioxide Nutrition 0.000 claims abstract description 7
QYFRTHZXAGSYGT-UHFFFAOYSA-L hexaaluminum dipotassium dioxosilane oxygen(2-) difluoride hydrate Chemical compound O.[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[O--].[F-].[F-].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[Al+3].[K+].[K+].O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O.O=[Si]=O QYFRTHZXAGSYGT-UHFFFAOYSA-L 0.000 claims abstract 4
239000003086 colorant Substances 0.000 claims description 103
GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 claims description 53
UQSXHKLRYXJYBZ-UHFFFAOYSA-N Iron oxide Chemical compound [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 claims description 49
239000000975 dye Substances 0.000 claims description 38
239000004408 titanium dioxide Substances 0.000 claims description 22
239000010445 mica Substances 0.000 claims description 18
229910052618 mica group Inorganic materials 0.000 claims description 18
CGLVZFOCZLHKOH-UHFFFAOYSA-N 8,18-dichloro-5,15-diethyl-5,15-dihydrodiindolo(3,2-b:3',2'-m)triphenodioxazine Chemical compound CCN1C2=CC=CC=C2C2=C1C=C1OC3=C(Cl)C4=NC(C=C5C6=CC=CC=C6N(C5=C5)CC)=C5OC4=C(Cl)C3=NC1=C2 CGLVZFOCZLHKOH-UHFFFAOYSA-N 0.000 claims description 8
XCJYREBRNVKWGJ-UHFFFAOYSA-N copper(II) phthalocyanine Chemical compound [Cu+2].C12=CC=CC=C2C(N=C2[N-]C(C3=CC=CC=C32)=N2)=NC1=NC([C]1C=CC=CC1=1)=NC=1N=C1[C]3C=CC=CC3=C2[N-]1 XCJYREBRNVKWGJ-UHFFFAOYSA-N 0.000 claims description 8
YGANSGVIUGARFR-UHFFFAOYSA-N dipotassium dioxosilane oxo(oxoalumanyloxy)alumane oxygen(2-) Chemical compound [O--].[K+].[K+].O=[Si]=O.O=[Al]O[Al]=O YGANSGVIUGARFR-UHFFFAOYSA-N 0.000 claims description 8
229910052627 muscovite Inorganic materials 0.000 claims description 8
IEQIEDJGQAUEQZ-UHFFFAOYSA-N phthalocyanine Chemical compound N1C(N=C2C3=CC=CC=C3C(N=C3C4=CC=CC=C4C(=N4)N3)=N2)=C(C=CC=C2)C2=C1N=C1C2=CC=CC=C2C4=N1 IEQIEDJGQAUEQZ-UHFFFAOYSA-N 0.000 claims description 8
239000002904 solvent Substances 0.000 claims description 7
WGLPBDUCMAPZCE-UHFFFAOYSA-N Trioxochromium Chemical compound O=[Cr](=O)=O WGLPBDUCMAPZCE-UHFFFAOYSA-N 0.000 claims description 5
229910000423 chromium oxide Inorganic materials 0.000 claims description 5
XMDMAACDNUUUHQ-UHFFFAOYSA-N vat orange 1 Chemical compound C1=CC(C2=O)=C3C4=C1C1=CC=CC=C1C(=O)C4=CC=C3C1=C2C(Br)=CC=C1Br XMDMAACDNUUUHQ-UHFFFAOYSA-N 0.000 claims description 4
239000004986 Cholesteric liquid crystals (ChLC) Substances 0.000 claims description 3
230000008859 change Effects 0.000 abstract description 16
238000013461 design Methods 0.000 description 425
239000010410 layer Substances 0.000 description 182
210000000554 iris Anatomy 0.000 description 151
239000000203 mixture Substances 0.000 description 71
239000000463 material Substances 0.000 description 59
238000007639 printing Methods 0.000 description 58
238000000034 method Methods 0.000 description 57
230000002093 peripheral effect Effects 0.000 description 30
BDERNNFJNOPAEC-UHFFFAOYSA-N propan-1-ol Chemical compound CCCO BDERNNFJNOPAEC-UHFFFAOYSA-N 0.000 description 30
210000001747 pupil Anatomy 0.000 description 29
238000004519 manufacturing process Methods 0.000 description 28
230000003287 optical effect Effects 0.000 description 28
238000012055 resonant mass measurement Methods 0.000 description 27
235000013968 mica-based pearlescent pigment Nutrition 0.000 description 26
230000007704 transition Effects 0.000 description 26
239000000243 solution Substances 0.000 description 24
230000001179 pupillary effect Effects 0.000 description 23
235000013980 iron oxide Nutrition 0.000 description 22
230000004438 eyesight Effects 0.000 description 20
229920001577 copolymer Polymers 0.000 description 18
SZVJSHCCFOBDDC-UHFFFAOYSA-N ferrosoferric oxide Chemical compound O=[Fe]O[Fe]O[Fe]=O SZVJSHCCFOBDDC-UHFFFAOYSA-N 0.000 description 18
230000001886 ciliary effect Effects 0.000 description 17
239000000017 hydrogel Substances 0.000 description 15
229920000642 polymer Polymers 0.000 description 15
210000003205 muscle Anatomy 0.000 description 14
WOBHKFSMXKNTIM-UHFFFAOYSA-N Hydroxyethyl methacrylate Chemical compound CC(=C)C(=O)OCCO WOBHKFSMXKNTIM-UHFFFAOYSA-N 0.000 description 13
238000002156 mixing Methods 0.000 description 13
KIWATKANDHUUOB-UHFFFAOYSA-N propan-2-yl 2-hydroxypropanoate Chemical compound CC(C)OC(=O)C(C)O KIWATKANDHUUOB-UHFFFAOYSA-N 0.000 description 13
NLAIHECABDOZBR-UHFFFAOYSA-M sodium 2,2-bis(2-methylprop-2-enoyloxymethyl)butyl 2-methylprop-2-enoate 2-hydroxyethyl 2-methylprop-2-enoate 2-methylprop-2-enoate Chemical compound [Na+].CC(=C)C([O-])=O.CC(=C)C(=O)OCCO.CCC(COC(=O)C(C)=C)(COC(=O)C(C)=C)COC(=O)C(C)=C NLAIHECABDOZBR-UHFFFAOYSA-M 0.000 description 13
CERQOIWHTDAKMF-UHFFFAOYSA-N Methacrylic acid Chemical compound CC(=C)C(O)=O CERQOIWHTDAKMF-UHFFFAOYSA-N 0.000 description 12
QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 12
229940067573 brown iron oxide Drugs 0.000 description 12
238000009472 formulation Methods 0.000 description 12
230000004927 fusion Effects 0.000 description 12
PCHJSUWPFVWCPO-UHFFFAOYSA-N gold Chemical compound [Au] PCHJSUWPFVWCPO-UHFFFAOYSA-N 0.000 description 12
229910052737 gold Inorganic materials 0.000 description 12
239000010931 gold Substances 0.000 description 12
239000001301 oxygen Substances 0.000 description 12
229910052760 oxygen Inorganic materials 0.000 description 12
239000003973 paint Substances 0.000 description 12
238000012937 correction Methods 0.000 description 11
239000003085 diluting agent Substances 0.000 description 11
239000001034 iron oxide pigment Substances 0.000 description 11
WTFXARWRTYJXII-UHFFFAOYSA-N iron(2+);iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[O-2].[Fe+2].[Fe+3].[Fe+3] WTFXARWRTYJXII-UHFFFAOYSA-N 0.000 description 11
239000000178 monomer Substances 0.000 description 11
238000004806 packaging method and process Methods 0.000 description 11
230000000007 visual effect Effects 0.000 description 11
229920002818 (Hydroxyethyl)methacrylate Polymers 0.000 description 10
JOLQKTGDSGKSKJ-UHFFFAOYSA-N 1-ethoxypropan-2-ol Chemical compound CCOCC(C)O JOLQKTGDSGKSKJ-UHFFFAOYSA-N 0.000 description 10
239000004793 Polystyrene Substances 0.000 description 10
239000011230 binding agent Substances 0.000 description 10
229910021641 deionized water Inorganic materials 0.000 description 10
PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 9
WNAHIZMDSQCWRP-UHFFFAOYSA-N dodecane-1-thiol Chemical compound CCCCCCCCCCCCS WNAHIZMDSQCWRP-UHFFFAOYSA-N 0.000 description 9
JEIPFZHSYJVQDO-UHFFFAOYSA-N iron(III) oxide Inorganic materials O=[Fe]O[Fe]=O JEIPFZHSYJVQDO-UHFFFAOYSA-N 0.000 description 9
-1 brown iron oxide Chemical compound 0.000 description 8
238000000576 coating method Methods 0.000 description 8
229920001519 homopolymer Polymers 0.000 description 8
238000007649 pad printing Methods 0.000 description 8
229920001296 polysiloxane Polymers 0.000 description 8
239000002356 single layer Substances 0.000 description 8
102100035526 B melanoma antigen 1 Human genes 0.000 description 7
101000874316 Homo sapiens B melanoma antigen 1 Proteins 0.000 description 7
239000004743 Polypropylene Substances 0.000 description 7
STVZJERGLQHEKB-UHFFFAOYSA-N ethylene glycol dimethacrylate Substances CC(=C)C(=O)OCCOC(=O)C(C)=C STVZJERGLQHEKB-UHFFFAOYSA-N 0.000 description 7
239000011159 matrix material Substances 0.000 description 7
239000004033 plastic Substances 0.000 description 7
229920003023 plastic Polymers 0.000 description 7
XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 6
230000008901 benefit Effects 0.000 description 6
239000011248 coating agent Substances 0.000 description 6
230000007547 defect Effects 0.000 description 6
230000003806 hair structure Effects 0.000 description 6
208000016339 iris pattern Diseases 0.000 description 6
235000010482 polyoxyethylene sorbitan monooleate Nutrition 0.000 description 6
229920000053 polysorbate 80 Polymers 0.000 description 6
XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 6
DBCAQXHNJOFNGC-UHFFFAOYSA-N 4-bromo-1,1,1-trifluorobutane Chemical compound FC(F)(F)CCCBr DBCAQXHNJOFNGC-UHFFFAOYSA-N 0.000 description 5
KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 5
BQCADISMDOOEFD-UHFFFAOYSA-N Silver Chemical compound [Ag] BQCADISMDOOEFD-UHFFFAOYSA-N 0.000 description 5
OKKRPWIIYQTPQF-UHFFFAOYSA-N Trimethylolpropane trimethacrylate Chemical compound CC(=C)C(=O)OCC(CC)(COC(=O)C(C)=C)COC(=O)C(C)=C OKKRPWIIYQTPQF-UHFFFAOYSA-N 0.000 description 5
239000000654 additive Substances 0.000 description 5
239000003795 chemical substances by application Substances 0.000 description 5
238000004040 coloring Methods 0.000 description 5
230000001419 dependent effect Effects 0.000 description 5
238000005516 engineering process Methods 0.000 description 5
230000002708 enhancing effect Effects 0.000 description 5
238000011067 equilibration Methods 0.000 description 5
239000000945 filler Substances 0.000 description 5
238000010348 incorporation Methods 0.000 description 5
239000002932 luster Substances 0.000 description 5
239000013500 performance material Substances 0.000 description 5
230000035699 permeability Effects 0.000 description 5
229920002223 polystyrene Polymers 0.000 description 5
229910052709 silver Inorganic materials 0.000 description 5
239000004332 silver Substances 0.000 description 5
239000000758 substrate Substances 0.000 description 5
OZAIFHULBGXAKX-UHFFFAOYSA-N 2-(2-cyanopropan-2-yldiazenyl)-2-methylpropanenitrile Chemical compound N#CC(C)(C)N=NC(C)(C)C#N OZAIFHULBGXAKX-UHFFFAOYSA-N 0.000 description 4
IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 4
FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 4
229910052782 aluminium Inorganic materials 0.000 description 4
XAGFODPZIPBFFR-UHFFFAOYSA-N aluminium Chemical compound [Al] XAGFODPZIPBFFR-UHFFFAOYSA-N 0.000 description 4
201000009310 astigmatism Diseases 0.000 description 4
230000000295 complement effect Effects 0.000 description 4
210000004087 cornea Anatomy 0.000 description 4
230000003247 decreasing effect Effects 0.000 description 4
239000008367 deionised water Substances 0.000 description 4
238000005538 encapsulation Methods 0.000 description 4
239000011888 foil Substances 0.000 description 4
235000011187 glycerol Nutrition 0.000 description 4
239000001023 inorganic pigment Substances 0.000 description 4
230000010354 integration Effects 0.000 description 4
235000010213 iron oxides and hydroxides Nutrition 0.000 description 4
239000004407 iron oxides and hydroxides Substances 0.000 description 4
239000012860 organic pigment Substances 0.000 description 4
239000011347 resin Substances 0.000 description 4
229920005989 resin Polymers 0.000 description 4
229910000906 Bronze Inorganic materials 0.000 description 3
RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 3
LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 3
206010020675 Hypermetropia Diseases 0.000 description 3
230000002730 additional effect Effects 0.000 description 3
238000013459 approach Methods 0.000 description 3
230000015572 biosynthetic process Effects 0.000 description 3
KGBXLFKZBHKPEV-UHFFFAOYSA-N boric acid Chemical compound OB(O)O KGBXLFKZBHKPEV-UHFFFAOYSA-N 0.000 description 3
239000004327 boric acid Substances 0.000 description 3
238000005282 brightening Methods 0.000 description 3
239000010974 bronze Substances 0.000 description 3
KUNSUQLRTQLHQQ-UHFFFAOYSA-N copper tin Chemical compound [Cu].[Sn] KUNSUQLRTQLHQQ-UHFFFAOYSA-N 0.000 description 3
238000005034 decoration Methods 0.000 description 3
239000006185 dispersion Substances 0.000 description 3
238000007667 floating Methods 0.000 description 3
201000006318 hyperopia Diseases 0.000 description 3
230000004305 hyperopia Effects 0.000 description 3
229910052742 iron Inorganic materials 0.000 description 3
230000001788 irregular Effects 0.000 description 3
208000001491 myopia Diseases 0.000 description 3
230000004379 myopia Effects 0.000 description 3
238000002360 preparation method Methods 0.000 description 3
230000008569 process Effects 0.000 description 3
239000001054 red pigment Substances 0.000 description 3
230000009467 reduction Effects 0.000 description 3
239000007787 solid Substances 0.000 description 3
239000000126 substance Substances 0.000 description 3
238000002834 transmittance Methods 0.000 description 3
AVTLBBWTUPQRAY-UHFFFAOYSA-N 2-(2-cyanobutan-2-yldiazenyl)-2-methylbutanenitrile Chemical compound CCC(C)(C#N)N=NC(C)(CC)C#N AVTLBBWTUPQRAY-UHFFFAOYSA-N 0.000 description 2
WAEVWDZKMBQDEJ-UHFFFAOYSA-N 2-[2-(2-methoxypropoxy)propoxy]propan-1-ol Chemical compound COC(C)COC(C)COC(C)CO WAEVWDZKMBQDEJ-UHFFFAOYSA-N 0.000 description 2
OMIGHNLMNHATMP-UHFFFAOYSA-N 2-hydroxyethyl prop-2-enoate Chemical compound OCCOC(=O)C=C OMIGHNLMNHATMP-UHFFFAOYSA-N 0.000 description 2
OZAIFHULBGXAKX-VAWYXSNFSA-N AIBN Substances N#CC(C)(C)\N=N\C(C)(C)C#N OZAIFHULBGXAKX-VAWYXSNFSA-N 0.000 description 2
102100040409 Ameloblastin Human genes 0.000 description 2
101000891247 Homo sapiens Ameloblastin Proteins 0.000 description 2
FPCCDPXRNNVUOM-UHFFFAOYSA-N Hydroxycitronellol Chemical compound OCCC(C)CCCC(C)(C)O FPCCDPXRNNVUOM-UHFFFAOYSA-N 0.000 description 2
CERQOIWHTDAKMF-UHFFFAOYSA-M Methacrylate Chemical compound CC(=C)C([O-])=O CERQOIWHTDAKMF-UHFFFAOYSA-M 0.000 description 2
229910000831 Steel Inorganic materials 0.000 description 2
PPBRXRYQALVLMV-UHFFFAOYSA-N Styrene Chemical compound C=CC1=CC=CC=C1 PPBRXRYQALVLMV-UHFFFAOYSA-N 0.000 description 2
DKGAVHZHDRPRBM-UHFFFAOYSA-N Tert-Butanol Chemical compound CC(C)(C)O DKGAVHZHDRPRBM-UHFFFAOYSA-N 0.000 description 2
230000002159 abnormal effect Effects 0.000 description 2
230000000996 additive effect Effects 0.000 description 2
230000002411 adverse Effects 0.000 description 2
229920001400 block copolymer Polymers 0.000 description 2
239000012986 chain transfer agent Substances 0.000 description 2
230000007012 clinical effect Effects 0.000 description 2
210000000795 conjunctiva Anatomy 0.000 description 2
229910052802 copper Inorganic materials 0.000 description 2
239000010949 copper Substances 0.000 description 2
230000008021 deposition Effects 0.000 description 2
238000011161 development Methods 0.000 description 2
230000018109 developmental process Effects 0.000 description 2
238000010586 diagram Methods 0.000 description 2
GMSCBRSQMRDRCD-UHFFFAOYSA-N dodecyl 2-methylprop-2-enoate Chemical compound CCCCCCCCCCCCOC(=O)C(C)=C GMSCBRSQMRDRCD-UHFFFAOYSA-N 0.000 description 2
238000004043 dyeing Methods 0.000 description 2
230000008020 evaporation Effects 0.000 description 2
238000001704 evaporation Methods 0.000 description 2
230000006870 function Effects 0.000 description 2
125000001475 halogen functional group Chemical group 0.000 description 2
125000005395 methacrylic acid group Chemical group 0.000 description 2
229910052757 nitrogen Inorganic materials 0.000 description 2
230000037361 pathway Effects 0.000 description 2
229910052628 phlogopite Inorganic materials 0.000 description 2
229920002120 photoresistant polymer Polymers 0.000 description 2
201000010041 presbyopia Diseases 0.000 description 2
QQONPFPTGQHPMA-UHFFFAOYSA-N propylene Natural products CC=C QQONPFPTGQHPMA-UHFFFAOYSA-N 0.000 description 2
125000004805 propylene group Chemical group [H]C([H])([H])C([H])([*:1])C([H])([H])[*:2] 0.000 description 2
208000014733 refractive error Diseases 0.000 description 2
229910001220 stainless steel Inorganic materials 0.000 description 2
239000010935 stainless steel Substances 0.000 description 2
239000010959 steel Substances 0.000 description 2
238000003756 stirring Methods 0.000 description 2
230000001225 therapeutic effect Effects 0.000 description 2
238000012546 transfer Methods 0.000 description 2
125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 2
229920002554 vinyl polymer Polymers 0.000 description 2
230000004304 visual acuity Effects 0.000 description 2
WDQFELCEOPFLCZ-UHFFFAOYSA-N 1-(2-hydroxyethyl)pyrrolidin-2-one Chemical compound OCCN1CCCC1=O WDQFELCEOPFLCZ-UHFFFAOYSA-N 0.000 description 1
QFSNCROGCLRZHC-UHFFFAOYSA-N 2,3-dihydroxypropoxyboronic acid Chemical compound OCC(O)COB(O)O QFSNCROGCLRZHC-UHFFFAOYSA-N 0.000 description 1
VCYCUECVHJJFIQ-UHFFFAOYSA-N 2-[3-(benzotriazol-2-yl)-4-hydroxyphenyl]ethyl 2-methylprop-2-enoate Chemical compound CC(=C)C(=O)OCCC1=CC=C(O)C(N2N=C3C=CC=CC3=N2)=C1 VCYCUECVHJJFIQ-UHFFFAOYSA-N 0.000 description 1
XMLYCEVDHLAQEL-UHFFFAOYSA-N 2-hydroxy-2-methyl-1-phenylpropan-1-one Chemical compound CC(C)(O)C(=O)C1=CC=CC=C1 XMLYCEVDHLAQEL-UHFFFAOYSA-N 0.000 description 1
MSXVEPNJUHWQHW-UHFFFAOYSA-N 2-methylbutan-2-ol Chemical compound CCC(C)(C)O MSXVEPNJUHWQHW-UHFFFAOYSA-N 0.000 description 1
RCEJCSULJQNRQQ-UHFFFAOYSA-N 2-methylbutanenitrile Chemical compound CCC(C)C#N RCEJCSULJQNRQQ-UHFFFAOYSA-N 0.000 description 1
LXAHHHIGZXPRKQ-UHFFFAOYSA-N 5-fluoro-2-methylpyridine Chemical compound CC1=CC=C(F)C=N1 LXAHHHIGZXPRKQ-UHFFFAOYSA-N 0.000 description 1
LLQHSBBZNDXTIV-UHFFFAOYSA-N 6-[5-[[4-[2-(2,3-dihydro-1H-inden-2-ylamino)pyrimidin-5-yl]piperazin-1-yl]methyl]-4,5-dihydro-1,2-oxazol-3-yl]-3H-1,3-benzoxazol-2-one Chemical compound C1C(CC2=CC=CC=C12)NC1=NC=C(C=N1)N1CCN(CC1)CC1CC(=NO1)C1=CC2=C(NC(O2)=O)C=C1 LLQHSBBZNDXTIV-UHFFFAOYSA-N 0.000 description 1
MMNWSHJJPDXKCH-UHFFFAOYSA-N 9,10-dioxoanthracene-2-sulfonic acid Chemical compound C1=CC=C2C(=O)C3=CC(S(=O)(=O)O)=CC=C3C(=O)C2=C1 MMNWSHJJPDXKCH-UHFFFAOYSA-N 0.000 description 1
206010058646 Arcus lipoides Diseases 0.000 description 1
235000015440 Berlandiera lyrata Nutrition 0.000 description 1
240000009302 Berlandiera lyrata Species 0.000 description 1
NYUKLGYCTHATDE-UHFFFAOYSA-N C=CC=C.C=C.C1=CC=CC=C1 Chemical class C=CC=C.C=C.C1=CC=CC=C1 NYUKLGYCTHATDE-UHFFFAOYSA-N 0.000 description 1
241000692783 Chylismia claviformis Species 0.000 description 1
KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 1
BPQQTUXANYXVAA-UHFFFAOYSA-N Orthosilicate Chemical compound [O-][Si]([O-])([O-])[O-] BPQQTUXANYXVAA-UHFFFAOYSA-N 0.000 description 1
241000320126 Pseudomugilidae Species 0.000 description 1
XUIMIQQOPSSXEZ-UHFFFAOYSA-N Silicon Chemical compound [Si] XUIMIQQOPSSXEZ-UHFFFAOYSA-N 0.000 description 1
LFOXEOLGJPJZAA-UHFFFAOYSA-N [(2,6-dimethoxybenzoyl)-(2,4,4-trimethylpentyl)phosphoryl]-(2,6-dimethoxyphenyl)methanone Chemical compound COC1=CC=CC(OC)=C1C(=O)P(=O)(CC(C)CC(C)(C)C)C(=O)C1=C(OC)C=CC=C1OC LFOXEOLGJPJZAA-UHFFFAOYSA-N 0.000 description 1
230000002350 accommodative effect Effects 0.000 description 1
230000009471 action Effects 0.000 description 1
230000004075 alteration Effects 0.000 description 1
SXQXMCWCWVCFPC-UHFFFAOYSA-N aluminum;potassium;dioxido(oxo)silane Chemical group [Al+3].[K+].[O-][Si]([O-])=O.[O-][Si]([O-])=O SXQXMCWCWVCFPC-UHFFFAOYSA-N 0.000 description 1
208000008303 aniridia Diseases 0.000 description 1
239000007864 aqueous solution Substances 0.000 description 1
201000000351 arcus senilis Diseases 0.000 description 1
230000005540 biological transmission Effects 0.000 description 1
239000000872 buffer Substances 0.000 description 1
239000007975 buffered saline Substances 0.000 description 1
PBAYDYUZOSNJGU-UHFFFAOYSA-N chelidonic acid Natural products OC(=O)C1=CC(=O)C=C(C(O)=O)O1 PBAYDYUZOSNJGU-UHFFFAOYSA-N 0.000 description 1
238000006243 chemical reaction Methods 0.000 description 1
239000002131 composite material Substances 0.000 description 1
238000010276 construction Methods 0.000 description 1
238000007334 copolymerization reaction Methods 0.000 description 1
238000007865 diluting Methods 0.000 description 1
238000002845 discoloration Methods 0.000 description 1
CDMADVZSLOHIFP-UHFFFAOYSA-N disodium;3,7-dioxido-2,4,6,8,9-pentaoxa-1,3,5,7-tetraborabicyclo[3.3.1]nonane;decahydrate Chemical compound O.O.O.O.O.O.O.O.O.O.[Na+].[Na+].O1B([O-])OB2OB([O-])OB1O2 CDMADVZSLOHIFP-UHFFFAOYSA-N 0.000 description 1
238000009826 distribution Methods 0.000 description 1
229940079593 drug Drugs 0.000 description 1
239000003814 drug Substances 0.000 description 1
239000003623 enhancer Substances 0.000 description 1
238000001914 filtration Methods 0.000 description 1
235000013305 food Nutrition 0.000 description 1
239000007789 gas Substances 0.000 description 1
238000010438 heat treatment Methods 0.000 description 1
UCNNJGDEJXIUCC-UHFFFAOYSA-L hydroxy(oxo)iron;iron Chemical compound [Fe].O[Fe]=O.O[Fe]=O UCNNJGDEJXIUCC-UHFFFAOYSA-L 0.000 description 1
239000003999 initiator Substances 0.000 description 1
VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
238000000691 measurement method Methods 0.000 description 1
230000003278 mimic effect Effects 0.000 description 1
238000012986 modification Methods 0.000 description 1
230000004048 modification Effects 0.000 description 1
230000003387 muscular Effects 0.000 description 1
QYZFTMMPKCOTAN-UHFFFAOYSA-N n-[2-(2-hydroxyethylamino)ethyl]-2-[[1-[2-(2-hydroxyethylamino)ethylamino]-2-methyl-1-oxopropan-2-yl]diazenyl]-2-methylpropanamide Chemical compound OCCNCCNC(=O)C(C)(C)N=NC(C)(C)C(=O)NCCNCCO QYZFTMMPKCOTAN-UHFFFAOYSA-N 0.000 description 1
XLYOFNOQVPJJNP-UHFFFAOYSA-O oxonium Chemical compound [OH3+] XLYOFNOQVPJJNP-UHFFFAOYSA-O 0.000 description 1
QGWDKKHSDXWPET-UHFFFAOYSA-E pentabismuth;oxygen(2-);nonahydroxide;tetranitrate Chemical compound [OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[OH-].[O-2].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[Bi+3].[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O.[O-][N+]([O-])=O QGWDKKHSDXWPET-UHFFFAOYSA-E 0.000 description 1
229920003050 poly-cycloolefin Polymers 0.000 description 1
239000002861 polymer material Substances 0.000 description 1
238000006116 polymerization reaction Methods 0.000 description 1
229920001155 polypropylene Polymers 0.000 description 1
238000010526 radical polymerization reaction Methods 0.000 description 1
238000011160 research Methods 0.000 description 1
229910052710 silicon Inorganic materials 0.000 description 1
239000010703 silicon Substances 0.000 description 1
239000011780 sodium chloride Substances 0.000 description 1
230000006641 stabilisation Effects 0.000 description 1
238000011105 stabilization Methods 0.000 description 1
239000007858 starting material Substances 0.000 description 1
230000008685 targeting Effects 0.000 description 1
238000010998 test method Methods 0.000 description 1
229920001169 thermoplastic Polymers 0.000 description 1
239000012780 transparent material Substances 0.000 description 1
239000001052 yellow pigment Substances 0.000 description 1

Images

Classifications

- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C7/00—Optical parts
- G02C7/02—Lenses; Lens systems ; Methods of designing lenses
- G02C7/04—Contact lenses for the eyes
- G02C7/046—Contact lenses having an iris pattern
- G—PHYSICS
- G02—OPTICS
- G02C—SPECTACLES; SUNGLASSES OR GOGGLES INSOFAR AS THEY HAVE THE SAME FEATURES AS SPECTACLES; CONTACT LENSES
- G02C11/00—Non-optical adjuncts; Attachment thereof
- G02C11/02—Ornaments, e.g. exchangeable

Landscapes

Physics & Mathematics (AREA)
Health & Medical Sciences (AREA)
Ophthalmology & Optometry (AREA)
General Physics & Mathematics (AREA)
Optics & Photonics (AREA)
General Health & Medical Sciences (AREA)
Eyeglasses (AREA)
Inks, Pencil-Leads, Or Crayons (AREA)
Non-Silver Salt Photosensitive Materials And Non-Silver Salt Photography (AREA)
Pens And Brushes (AREA)

TW111111587A 2021-03-29 2022-03-28 改良美容效果的隱形眼鏡 TW202237756A (zh)

Applications Claiming Priority (4)

Application Number	Priority Date	Filing Date	Title
US202163167340P	2021-03-29	2021-03-29
US63/167,340		2021-03-29
US17/654,122		2022-03-09
US17/654,122 US20220306886A1 (en)	2021-03-29	2022-03-09	Contact lens with improved cosmesis

Publications (1)

Publication Number	Publication Date
TW202237756A true TW202237756A (zh)	2022-10-01

Family

ID=80820244

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
TW111111587A TW202237756A (zh)	2021-03-29	2022-03-28	改良美容效果的隱形眼鏡

Country Status (7)

Country	Link
EP (1)	EP4314940A1 (fr)
JP (1)	JP2024515395A (fr)
KR (1)	KR20230162526A (fr)
CN (1)	CN115698829A (fr)
AU (1)	AU2022247445A1 (fr)
TW (1)	TW202237756A (fr)
WO (1)	WO2022208205A1 (fr)

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI844287B (zh) *	2023-03-01	2024-06-01	王頌評	訂製型散光隱形眼鏡

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2025104612A1 (fr) *	2023-11-16	2025-05-22	Johnson & Johnson Vision Care, Inc.	Lentille de contact cosmétique ayant un motif de points elliptique approprié pour former un anneau limbique apparent

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US5944853A (en)	1992-10-26	1999-08-31	Johnson & Johnson Vision Products, Inc.	Method for preparing halotriazine dye- and vinyl sulfone dye-monomer compounds
JP4334204B2 (ja) *	2002-11-21	2009-09-30	メルク株式会社	高輝度高彩度虹彩顔料およびその製造方法
US7278736B2 (en) *	2004-02-25	2007-10-09	Novartis Ag	Contact lenses imparting a vivacious appearance to the eye
US7802883B2 (en) *	2007-12-20	2010-09-28	Johnson & Johnson Vision Care, Inc.	Cosmetic contact lenses having a sparkle effect
JP2013130716A (ja) *	2011-12-21	2013-07-04	Menicon Co Ltd	色付コンタクトレンズおよびその製造方法
US20170276959A1 (en) *	2016-03-22	2017-09-28	Johnson & Johnson Vision Care, Inc.	Contact lens with improved, multiple and integrated effects
KR101826601B1 (ko) *	2017-05-22	2018-02-07	주식회사 인터로조	광택성분이 함유된 콘택트렌즈

2022
- 2022-03-11 EP EP22711634.0A patent/EP4314940A1/fr not_active Withdrawn
- 2022-03-11 CN CN202280004964.6A patent/CN115698829A/zh active Pending
- 2022-03-11 JP JP2022574493A patent/JP2024515395A/ja active Pending
- 2022-03-11 KR KR1020227042789A patent/KR20230162526A/ko active Pending
- 2022-03-11 WO PCT/IB2022/052217 patent/WO2022208205A1/fr not_active Ceased
- 2022-03-11 AU AU2022247445A patent/AU2022247445A1/en active Pending
- 2022-03-28 TW TW111111587A patent/TW202237756A/zh unknown

Cited By (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
TWI844287B (zh) *	2023-03-01	2024-06-01	王頌評	訂製型散光隱形眼鏡

Also Published As

Publication number	Publication date
AU2022247445A1 (en)	2023-01-05
JP2024515395A (ja)	2024-04-10
CN115698829A (zh)	2023-02-03
KR20230162526A (ko)	2023-11-28
WO2022208205A1 (fr)	2022-10-06
EP4314940A1 (fr)	2024-02-07

Publication	Publication Date	Title
JP7282859B2 (ja)	2023-05-29	改善された複数の統合的効果を伴うコンタクトレンズ
US20220306886A1 (en)	2022-09-29	Contact lens with improved cosmesis
TWI902907B (zh)	2025-11-01	具有正反兩用效果之妝飾隱形眼鏡
JP6716199B2 (ja)	2020-07-01	真珠光沢の強膜を有するコンタクトレンズ
AU2007260934A1 (en)	2007-12-27	Tinted contact lenses having iris patterns with enhanced depth
TW202237756A (zh)	2022-10-01	改良美容效果的隱形眼鏡
RU2855972C1 (ru)	2026-02-06	Контактная линза с улучшенным косметическим эффектом
RU2842595C1 (ru)	2025-06-30	Косметическая контактная линза с двусторонними эффектами
HK40087594A (zh)	2023-09-08	具有改善的美容效果的接触镜片
HK40097225B (en)	2026-04-02	Cosmetic contact lens with reversible effects
HK40097225A (en)	2024-03-08	Cosmetic contact lens with reversible effects
HK1242788A1 (en)	2018-06-29	Contact lens with improved, multiple and integrated effects

TW202237756A - 改良美容效果的隱形眼鏡 - Google Patents

Info

Links

Images

Classifications

Landscapes

Applications Claiming Priority (4)

Publications (1)

Family

ID=80820244

Family Applications (1)

Country Status (7)

Cited By (1)

Families Citing this family (1)

Family Cites Families (7)

Cited By (1)

Also Published As

Similar Documents